CBDP (cannabidiphorol) has been shown to be similar in structure to the popular cannabinoid CBD but unlike CBD, CBDP possesses a longer side chain, a feature that is believed to serve a lot of beneficial purposes. In THCP, the cannabinoid discovered alongside CBDP, the longer side chain helps improve receptor bonding however this is not the case in CBDP. Studies currently show that CBDP doesn’t do much to improve the poor receptor binding ability of CBD although it should be noted that biological tests are still in their early stages so it’s still quite early to draw final conclusions.
Legal on paper, restricted in practice. Inside Germany’s cannabis system, where cultivation is allowed but…
The idea may sound strange: a tobacco plant producing compounds like psilocybin or DMT. Sounds…
The term “addiction” gets thrown around quite freely in everyday language—this is nothing new. Who…
Three days before the Trump administration moved medical marijuana to Schedule III, a new YouGov…
On April 23, 2026, the Trump administration officially moved FDA-approved marijuana products and marijuana products…
Here we are in 2026, and a conflict that was supposed to wrap up in…